CX717
CAS No. 867276-98-0
CX717 ( —— )
产品货号. M35376 CAS No. 867276-98-0
CX 717 是AMPA 受体的正变构调节剂。具有抗抑郁样作用。可用于成人注意力缺陷多动障碍(ADHD)的研究。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥227 | 有现货 |
|
| 10MG | ¥378 | 有现货 |
|
| 25MG | ¥742 | 有现货 |
|
| 50MG | ¥1097 | 有现货 |
|
| 100MG | ¥1791 | 有现货 |
|
| 200MG | ¥2367 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称CX717
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CX 717 是AMPA 受体的正变构调节剂。具有抗抑郁样作用。可用于成人注意力缺陷多动障碍(ADHD)的研究。
-
产品描述CX 717 is a positive allosteric modulator of AMPA receptor. Antidepressant-like effect. CX 717 can be used for the research of adult attention deficit hyperactivity disorder (ADHD).
-
体外实验——
-
体内实验CX 717 (CX717; 20 mg/kg) has a rapid (30 min) but short-lasting (up to 24 h) antidepressantlike effect in the forced swim test.CX 717 also produces a rapid (up to 1 h) increase of brain-derived neurotrophic factor (BDNF) and a more sustained (up to 6 h) increase of p11. Intra-cortical infusion of CX 717 (85 mM) increases the efflux of noradrenaline, dopamine, and serotonin, but not glutamate.Animal Model:Male Sprague-Dawley rats weighing 280-350 g Dosage:20 mg/kg (administered at 1 mL/kg) Administration:Intraperitoneal (i.p.) injection Result:Evoked antidepressant-like effects (20 mg/kg, i.p.) did not alter the extracellular concentrations of noradrenaline (NA), dopamine (DA), serotonin (5-HT) and glutamate in the medial prefrontal cortex (mPFC).
-
同义词——
-
通路Neuroscience
-
靶点GluR
-
受体GluR
-
研究领域——
-
适应症——
化学信息
-
CAS Number867276-98-0
-
分子量233.23
-
分子式C11H11N3O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO 中的溶解度 : 50 mg/mL (214.39 mM; 超声助溶 (<60°C)
-
SMILESO=C(N1CCOCC1)c1ccc2nonc2c1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Linda J Porrino, et al. Facilitation of task performance and removal of the effects of sleep deprivation by an ampakine (CX717) in nonhuman primates. PLoS Biol. 2005 Sep;3(9):e299.?
021-51111890
购物车()
sales@molnova.cn

